Publication:
The Effect of Tigecycline and Ertapenem Against Clinical Isolates of Brucella Melitensis Detected by E-Test on Different Media

dc.authorscopusid6503931859
dc.authorscopusid7007135107
dc.authorscopusid24479885000
dc.authorscopusid6602738477
dc.contributor.authorTanyel, E.
dc.contributor.authorÇoban, A.Y.
dc.contributor.authorTaşdelen Fişgm, N.
dc.contributor.authorTulek, N.
dc.date.accessioned2020-06-21T14:46:58Z
dc.date.available2020-06-21T14:46:58Z
dc.date.issued2010
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Tanyel] Esra Aksakal, Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Çoban] Ahmet Yilmaz, Department of Microbiology and Clinical Microbiology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Taşdelen Fişgm] Nuriye, Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Tulek] N. Eren, Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractIn this study, in vitro activity of tigecycline (TIG) and ertapenem (ERT) against clinical isolates of Brucella melitensis and the effect of different media on in vitro test results were investigated. The in vitro effects of TIG and ERT to 38 B. melitensis isolates were comparatively investigated in brucella agar and 5% sheep blood agar. MIC value of ERT was 0.032 g/mL in 23 of 38 and 20 of 38 isolates on blood and brucella agar, respectively. Minimum inhibitory concentration values of TIG were substantially different ranging between 0.064-0.25 g/mL on blood agar. However, MIC values of TIG were similar on brucella agar with 0.25 g/mL in 15 of 38 isolates and 0.5 g/mL in 10 of 38 isolates. In conclusion, although ERT and TIG were effective against B. melitensis isolates in vitro, further studies are needed in order to determine the use of these novel drugs in treatment of brucellosis.en_US
dc.identifier.doi10.4103/0255-0857.71822
dc.identifier.endpage371en_US
dc.identifier.issn0255-0857
dc.identifier.issn1998-3646
dc.identifier.issue4en_US
dc.identifier.pmid20966572
dc.identifier.scopus2-s2.0-78149456421
dc.identifier.scopusqualityQ4
dc.identifier.startpage370en_US
dc.identifier.urihttps://doi.org/10.4103/0255-0857.71822
dc.identifier.volume28en_US
dc.identifier.wosWOS:000283919300020
dc.identifier.wosqualityQ4
dc.language.isoenen_US
dc.publisherWolters Kluwer Medknow Publicationsen_US
dc.relation.ispartofIndian Journal of Medical Microbiologyen_US
dc.relation.journalIndian Journal of Medical Microbiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBrucellosisen_US
dc.subjectErtapenemen_US
dc.subjectTigecyclineen_US
dc.titleThe Effect of Tigecycline and Ertapenem Against Clinical Isolates of Brucella Melitensis Detected by E-Test on Different Mediaen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files